News, views and contacts from the global Pharmaceutical industry
25 May 2017
Industry News

Selexis and OSE Immunotherapeutics to support OSE-127 (Effi-7) development
Swiss-based Selexis has signed a commercial licence agreement to provide French biotechnology firm OSE Immunotherapeutics with access to high-performance research cell banks (RCBs) from its SUREtechnology Platform.

FDA approves Sanofi and Regeneron’s Kevzara for adult rheumatoid arthritis
Sanofi and Regeneron Pharmaceuticals’ drug Kevzara (sarilumab) has received the US Food and Drug Administration (FDA) approval to treat adult patients affected with moderately to severely active rheumatoid arthritis (RA).

UK CMA accuses Merck of breaking competition law with discount scheme
The UK Competition and Markets Authority (CMA) has accused US pharmaceutical company Merck Sharp & Dohme (MSD) of operating an anti-competitive discount scheme for its medicine Remicade.

Ardelyx’s first-in-class NHE3 blocker Tenapanor boasts positive phase III data
On May 12, Ardelyx, a US-based clinical-stage company focused on the development of treatments for cardio-renal and gastrointestinal (GI) diseases, announced positive top-line results from the T3MPO-1 Phase III study for the use of tenapanor to treat patients with constipation predominant Irritable Bowel Syndrome (IBS-C).

Press Releases

Upcoming Quality Assurance and Regulatory Adherence Courses by NSF
NSF International has released a list of upcoming courses for June and July.

What is a Biosimilar and How Does it Differ Compared to Drug Development?
Prior to 23 March 2010, there was no regulatory pathway for biosimilar development in the US.

BLUE Software Celebrates 20th Anniversary
To celebrate its 20th anniversary, BLUE Software has announced it will introduce new software as a service (SaaS) products BLUE Essentials, BLUE Premier, and BLUE Enterprise to its label and artwork management (LAM) technology.

Prudential Cleanroom Services Completes Surveillance Audits
Prudential Cleanroom Services has announced that it has completed its surveillance audits for ISO 9001:2008 through TÜV SÜD America.

NSF International to Attend 2nd PDA Europe Annual Meeting, Germany
NSF International's pharma biotech team has announced it will be present at the 2nd PDA Europe Annual Meeting in Berlin.

White Papers

Flexible Drug Containers for Parenteral Drugs
Self-medication is becoming more popular, driven by cost considerations. Valuable time of healthcare personnel and the high cost of hospital stays are outweighing the costs of treatment...

Rules for Investigating Good Manufacturing Practice (GMP) Deviations in Sterile Processing
When things go wrong, there are five non-negotiable processes that should be defined on your deviation investigation standards of practice (SOP): immediate engagement, gemba, triaging using...

Guide to Pharmaceutical Labelling Excellence
BLUE has created the articles and tools in this guide to help you focus on key activities essential for energising transformation in your organisation....

Autoclaves, Sterilisers, and Thermal Equipment for the Laboratory, Research, and Medical Industry
LTE Scientific's new Touchclave EcoTech autoclave combined a high level of standard features with exceptionally low energy and water...

Solving Complex Pharmaceuticals Dosing Tasks
For dosing and filling in the pharmaceutical industry, you usually think of water-like, non-viscous products such as solutions for...

Follow Us:   Facebook Facebook    Twitter Twitter   
Click here to unsubscribe from the newsletter | Privacy Policy
You are receiving this email because you are either a valued subscriber to Pharmaceutical Technology or have signed up via a partner web site. Your email address has not been, and will not be, given to third parties. is a product of Kable. Copyright 2017 Kable, a trading division of Kable Intelligence Limited.